Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0163 | 0.1429 | 0.6038 |
Echinococcus multilocularis | neuroglian | 0.0201 | 0.2248 | 0.4662 |
Echinococcus granulosus | twitchin | 0.0201 | 0.2248 | 0.0956 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0223 | 0.2718 | 0.7338 |
Loa Loa (eye worm) | hypothetical protein | 0.0207 | 0.2367 | 0.5338 |
Echinococcus multilocularis | roundabout 2 | 0.0244 | 0.3186 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0244 | 0.3186 | 1 |
Schistosoma mansoni | nephrin | 0.0201 | 0.2248 | 0.9498 |
Echinococcus granulosus | neuroglian | 0.0201 | 0.2248 | 0.0956 |
Schistosoma mansoni | cell adhesion molecule | 0.0207 | 0.2367 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0223 | 0.2718 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0207 | 0.2367 | 0.1094 |
Loa Loa (eye worm) | hypothetical protein | 0.0244 | 0.3186 | 1 |
Schistosoma mansoni | vesicular amine transporter | 0.0163 | 0.1429 | 0.6038 |
Echinococcus granulosus | roundabout 2 | 0.0244 | 0.3186 | 0.205 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0163 | 0.1429 | 0.6038 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Efficacy (functional) | = 1 % | Percent efficacy of the compound for inhibition of glucose stimulated insulin release from beta TC6 cells | ChEMBL. | 15501029 |
Efficacy (functional) | = 1 % | Percent efficacy of the compound for inhibition of glucose stimulated insulin release from beta TC6 cells | ChEMBL. | 15501029 |
IC50 (functional) | NS 0 uM | inhibitory concentration required for repolarisation of beta cell membrane potential in presence of 10 mM glucose | ChEMBL. | 15501029 |
IC50 (functional) | = 26.62 uM | Concentration required for inhibition of glucose stimulated insulin release from beta TC6 cells | ChEMBL. | 15501029 |
IC50 (functional) | = 26.62 uM | Concentration required for inhibition of glucose stimulated insulin release from beta TC6 cells | ChEMBL. | 15501029 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.